0001367644-20-000013.txt : 20200225 0001367644-20-000013.hdr.sgml : 20200225 20200225163042 ACCESSION NUMBER: 0001367644-20-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200221 FILED AS OF DATE: 20200225 DATE AS OF CHANGE: 20200225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Richard Ronald CENTRAL INDEX KEY: 0001380177 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 20651120 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 wf-form4_158266622472686.xml FORM 4 X0306 4 2020-02-21 0 0001367644 Emergent BioSolutions Inc. EBS 0001380177 Richard Ronald 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2020-02-21 4 M 0 5152 18.64 A 31851 D Common Stock 2020-02-21 4 S 0 5152 65 D 16395 D Employee Stock Options (Right to Buy) 18.64 2020-02-21 4 M 0 5152 18.64 D 2017-05-21 2021-05-21 Common Stock 5152.0 7893 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard. Consists of an option granted under the company's stock incentive plan as amended and restated. The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. The date herein represents the third anniversary date of the grant and the final vesting date. /s/ S. Scott Lieberman, Attorney-in-fact 2020-02-25